Cargando…
Complete disease remission in a TP53 and KRAS co-mutated brain oligometastatic lung cancer patient after immuno-chemotherapy and surgical resection: a case report
Lung cancer is the most common primary malignancy and tends to metastasize to the brain. A multimodal approach, including systematic therapy (targeted therapy, chemotherapy, immunotherapy) and local consolidative therapy (surgical intervention, radiation therapy, ablation therapy), is essential for...
Autores principales: | Zhu, Shuai, Zhao, Shikang, Zhang, Qian, Li, Shuo, Ren, Dian, Ren, Fan, Zu, Lingling, Wang, Yanye, Lei, Xi, Zhou, Ning, Shi, Tao, Xu, Dongbo, Chen, Gang, Lim, Wan-Teck, Giusti, Raffaele, Wu, Abraham J., Xu, Song |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8182723/ https://www.ncbi.nlm.nih.gov/pubmed/34164277 http://dx.doi.org/10.21037/tlcr-21-380 |
Ejemplares similares
-
Primary ciliated muconodular papillary tumor: A rare pulmonary disease and literature review of 65 cases
por: Wang, Yanye, et al.
Publicado: (2021) -
KRAS and TP53 Mutations in Colorectal Carcinoma
por: Al-Kuraya, Khawla S.
Publicado: (2009) -
Genetic alterations of KRAS and TP53 in intrahepatic cholangiocarcinoma associated with poor prognosis
por: Peng, Jianbo, et al.
Publicado: (2023) -
Induction of pancreatic neoplasia in the KRAS/TP53 Oncopig
por: Mondal, Pinaki, et al.
Publicado: (2023) -
KRAS/LKB1 and KRAS/TP53 co-mutations create divergent immune signatures in lung adenocarcinomas
por: Gu, Meichen, et al.
Publicado: (2021)